Purchase Order HHSN261201700680P
Award Date 9/16/17
Potential Completion Date 9/16/22
Potential Value $126K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $750,000.00 firm fixed price purchase order contract awarded by the National Cancer Institute to Becton, Dickinson & Co (BD) for a special order BD Biosciences LSRFortessa X-30 flow cytometer. The contract has no set-aside designation. BD is a manufacturer and supplier of medical devices, instruments, reagents, and related products to healthcare institutions, clinical laboratories, pharmaceutical companies, and the general public. BD has received numerous federal contract awards as...
- This is a $99,717.48 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, to Becton, Dickinson and Company (BD). The contract is for the provision of three LSR FORTESSA flow cytometers with laser systems, as well as an annual service agreement. There is no set-aside designation for this award. BD is a major manufacturer of medical devices, instruments, and supplies, including...
- This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for the pre-contract inspection of a BD LSRFortessa 4B/2R/2UV 3 laser flow cytometry instrument. The $15,000.00 contract does not have a set-aside designation, reflecting BD's competitive position as a large, established manufacturer of medical technologies and laboratory equipment. The LSRFortessa instrument is...
- This federal contract award is for an annual service agreement with Becton, Dickinson and Company (BD) to provide three LSRFortessa flow cytometers, associated lasers, and one FACS flow supply system to the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the National Institutes of Health (NIH). The $93,612.48 firm fixed-price purchase order does not utilize a small business set-aside. BD, a large medical technology manufacturer, has a long-standing...
- This is a $379,912 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Becton, Dickinson and Company (BD) for an LSRFORTESSA X20 flow cytometer. The contract has no set-aside designation and was awarded on July 19, 2016, with a completion date of August 26, 2016. BD is a global medical technology company that provides a wide range of instruments, reagents, and services to...
- This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services (HHS), to Becton, Dickinson and Company (BD) for $129,402.16 to provide maintenance services for government-owned BD LSRFORTESSA SORP flow cytometry cell analyzers. The contract has a period of performance from February 23, 2017 through February 28, 2022. BD, a leading manufacturer of medical devices and diagnostics, has received numerous federal prime...
- This federal contract was awarded by the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations to Becton, Dickinson And Company (BD), a global medical technology company. The contract is for the maintenance support of a LSRFORTESSA flow cytometry system, a specialized instrument used in biomedical research and clinical applications. The contract is a firm fixed-price purchase order with a potential value of $126,944.40 and a...
- This is a firm fixed-price delivery order awarded by the National Institutes of Health (NIH), National Cancer Institute to Becton, Dickinson And Company (BD) for the procurement of a LSRFORTESSA flow cytometer. The contract is under the General Services Administration (GSA) Scientific Equipment and Services schedule (FSS-66) and does not have a set-aside designation. The potential value of the award is $154,229.54. BD is a global medical technology company that provides a wide range of...
- This is a $700,580.86 firm fixed-price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI), part of the U.S. Department of Health and Human Services, to Becton, Dickinson and Company (BD) for a service maintenance plan for BD LSR Fortessa SORP flow cytometers with high-throughput and BD Influx flow cytometers with lasers. The contract has an ultimate completion date of August 16, 2022 and was awarded on August 9, 2017 without a set-aside designation, indicating BD's...
- This is a $32,850 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, to Becton, Dickinson and Company (BD) for a service agreement to maintain the LSRFORTESSA SORP and associated blue, red, and violet lasers. The contract does not have a set-aside designation. BD, a major manufacturer of medical devices and laboratory equipment, has received numerous federal contract and subcontract...